Product Highlight - LATUDA

LATUDA – Lurasidone HCl 20 mg for Depressive Episodes Associated with Bipolar I Disorder (bipolar depression*)
LATUDA helps your patients with bipolar depression* experience more of life’s everyday moments

• Monotherapy treatment of adult and adolescent patients (13 to 17 years) patients with major depressive episode associated with bipolar I disorder (bipolar depression)¹
• Adjunctive treatment with lithium or valproate in adult patients with major depressive episode associated with bipolar I disorder (bipolar depression)¹
• Initial dose titration is not required¹
• LATUDA is safe and well tolerated, with little effect on weight, lipid and glucose metabolism²
• LATUDA is well tolerated with a favorable safety profile²
*Depressive episodes associated with bipolar I disorder

References:
1. LATUDA 20 mg product information (Jul 2021)
2. Pikalov A, et al. Long-term use of lurasidone in patients with bipolar disorder: safety and effectiveness over 2 years of treatment. Int J Bipolar Disord 2017;5:9.

DA-20220915-02